Project Information

Bid Title

Notice of Intent to Sole Source – Oncotype DX Cancer Testing Services

Issuing Agency

DEPT OF DEFENSE

Location

Nevada

Published Date

Sep 7, 2026

Closing Date

Sep 11, 2026

Government Level

Federal

Status

Closed

Ref. #

HT941026N0123

Original Source

Join to Access Full Details

Bid Inquiries

Join to Access Full Details

Bid Documents

Join to Access Full Details

Set Aside

No Set aside used

Project Description

Follow

Notice of Intent to Sole Source – Oncotype DX Cancer Testing Services

Active

Contract Opportunity

Notice ID

HT941026N0123

Related Notice

Department/Ind. Agency

DEPT OF DEFENSE

Sub-tier

DEFENSE HEALTH AGENCY (DHA)

Office

DEFENSE HEALTH AGENCY HCD WEST

General Information View Changes

• Contract Opportunity Type: Special Notice (Updated)
• Updated Published Date: Sep 06, 2026 09:09 pm PDT
• Original Published Date: Sep 06, 2026 09:08 pm PDT
• Updated Response Date: Sep 11, 2026 10:00 am PDT
• Original Response Date: Sep 11, 2026 10:00 am PDT
• Inactive Policy: 15 days after response date
• Updated Inactive Date: Sep 26, 2026
• Original Inactive Date: Sep 26, 2026
• Initiative:

Classification

• Original Set Aside: No Set aside used
• Product Service Code: Q301 - REFERENCE LABORATORY TESTING
• NAICS Code:
  • 621511 - Medical Laboratories
• Place of Performance:
  Nellis AFB , NV 89191
  USA

Description

The Defense Health Agency Contracting Activity, Healthcare Contracting Division–West, intends to negotiate and award a firm-fixed-price sole-source contract to Genomic Health, Inc., an Exact Sciences company, for Oncotype DX Cancer Testing Services in support of Mike O’Callaghan Military Medical Center, Nellis AFB, Nevada.

The requirement is for the specific Oncotype DX branded genomic tumor-testing service and associated report for eligible patients. The contractor shall provide materials necessary for specimen submission, perform required testing at the contractor’s facility, provide written test results and interpretation, and return tissue tumor blocks or unstained slides in accordance with the resulting contract.

The anticipated period of performance is 16 September 2026 through 15 September 2027, with four 12-month option periods and a potential six-month extension. This is a Notice of Intent to Sole Source and is not a request for competitive quotations or proposals. Interested sources may submit a capability statement by the response deadline stated in this notice.

Attachments/Links

Contact Information

Contracting Office Address

• 2739T ROOSEVELT DRIVE OFFICE 143, BUILDING H-201T
• CAMP PENDLETON , CA 92055
• USA

Primary Point of Contact

• Dominic Gonzales
• dominic.n.gonzales.civ@health.mil

Secondary Point of Contact

• Brandi Roberts
• brandi.m.roberts5.civ@health.mil

History

• Sep 06, 2026 09:09 pm PDTSpecial Notice (Updated)
• Sep 06, 2026 09:08 pm PDT Special Notice (Original)

Commodity Codes

• FSC QMedical Services

• NAICS 621511Medical Laboratories

Related bids

Sep 9, 2026

[Special Notice (Updated)] Notice of Intent to Sole Source – Oncotype DX Cancer Testing Services

* Disclaimer: Government BidHub provides information on bids, RFPs (Requests for Proposals), and RFQs (Requests for Qualifications) solely for convenience and informational purposes. This site is not an official public notice board. For official details, responses, or inquiries, please contact the relevant government agency directly.